Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
143.63
+0.59 (0.41%)
Nov 12, 2024, 4:00 PM EST - Market closed
Glaukos Employees
Glaukos had 907 employees as of December 31, 2023. The number of employees increased by 124 or 15.84% compared to the previous year.
Employees
907
Change (1Y)
124
Growth (1Y)
15.84%
Revenue / Employee
$397,295
Profits / Employee
-$164,907
Market Cap
7.92B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 907 | 124 | 15.84% |
Dec 31, 2022 | 783 | 56 | 7.70% |
Dec 31, 2021 | 727 | 74 | 11.33% |
Dec 31, 2020 | 653 | 53 | 8.83% |
Dec 31, 2019 | 600 | 163 | 37.30% |
Dec 31, 2018 | 437 | 50 | 12.92% |
Dec 31, 2017 | 387 | 123 | 46.59% |
Dec 31, 2016 | 264 | 82 | 45.05% |
Dec 31, 2015 | 182 | 56 | 44.44% |
Dec 31, 2014 | 126 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Walgreens Boots Alliance | 331,000 |
The Ensign Group | 35,300 |
Henry Schein | 25,000 |
Chemed | 15,087 |
Bruker | 9,707 |
Jazz Pharmaceuticals | 2,800 |
Repligen | 1,783 |
Ascendis Pharma | 879 |
GKOS News
- 4 days ago - Glaukos Announces Participation in Upcoming Investor Conferences - Business Wire
- 7 days ago - Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds - Benzinga
- 8 days ago - Glaukos Corporation (GKOS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Glaukos Announces Third Quarter 2024 Financial Results - Business Wire
- 27 days ago - Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety - Business Wire
- 4 weeks ago - Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting - Business Wire
- 4 weeks ago - Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4 - Business Wire
- 7 weeks ago - Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement - GlobeNewsWire